386
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluations

Aripiprazole for the treatment of bipolar disorder: a review of current evidence

, MD, , MD, , DEcon, , MD & , MD
Pages 473-488 | Published online: 22 Jan 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alessandro Cuomo, Bruno Beccarini Crescenzi, Arianna Goracci, Simone Bolognesi, Nicola Giordano, Rodolfo Rossi, Edvige Facchi, Stephen M Neal & Andrea Fagiolini. (2019) Drug safety evaluation of aripiprazole in bipolar disorder. Expert Opinion on Drug Safety 18:6, pages 455-463.
Read now
Luiz Dratcu, Sotonte Bobmanuel, Wendy Davies, Alan Farmer, Mohan George, Tanvir Rana, Mala Singh & Martin Turner. (2012) A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania. International Journal of Psychiatry in Clinical Practice 16:4, pages 244-258.
Read now

Articles from other publishers (5)

Baybars Veznedaroglu, Nesrin Dilbaz, Ozcan Uzun & Erdal Isik. (2018) TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- consensus recommendations by a Turkish multidisciplinary panel. Therapeutic Advances in Psychopharmacology 8:10, pages 271-285.
Crossref
Andrea de Bartolomeis, Livia Avvisati, Felice Iasevoli & Carmine Tomasetti. (2013) Intracellular pathways of antipsychotic combined therapies: Implication for psychiatric disorders treatment. European Journal of Pharmacology 718:1-3, pages 502-523.
Crossref
Maria Paola Rapagnani. (2012) Safety, Efficacy, and Patient Acceptability of Aripiprazole in the Maintenance Treatment of Bipolar Disorder. Clinical Medicine Insights: Therapeutics 4, pages CMT.S7388.
Crossref
Sohita Dhillon. (2012) Aripiprazole. Drugs 72:1, pages 133-162.
Crossref
Lisa C. Lloyd, Giovanni Giaroli, David Taylor & Derek K. Tracy. (2011) Bipolar depression: clinically missed, pharmacologically mismanaged. Therapeutic Advances in Psychopharmacology 1:5, pages 153-162.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.